Abstract
Approximately 10% of patients with polycythemia vera (PV) transform to acute leukemia (blast phase) at 10 years after initial diagnosis of PV. The bone marrow pathologic, cytogenetic, and molecular features of blast phase have not been well characterized. In this study, we reviewed 422 PV patients over a period of 11 years and identified 58 patients who developed acute myeloid leukemia (blast phase) during the course of disease. We found that blast phase of PV was characterized by overt myelodysplasia (n = 51, 88%); moderate to severe myelofibrosis (33 of 45, 73%); an abnormal karyotype (n = 51, 88%) that was often complex karyotype (n = 42, 72%); and gene mutations involving TP53 (55%), TET2 (27%), and DNMT3A (25%). Patients with blast phase of PV had an aggressive clinical course, with a median overall survival of 4 months after onset of blast phase. Eleven patients had close follow-up from polycythemic phase to blast phase: Four patients showed dysplastic changes in the polycythemic phase, and three of them transformed to blast phase without a "middle phase" of post-PV myelofibrosis.We conclude that blast phase of PV is characterized by myelodysplasia, moderate to severe fibrosis, a high frequency of an abnormal and often co...Continue Reading
References
Oct 1, 1979·British Journal of Haematology·A ManoharanW R Pitney
Sep 1, 1977·Scandinavian Journal of Haematology·A WeinfeldB Swolin
Feb 26, 1999·Leukemia & Lymphoma·M CamósE Montserrat
Dec 9, 2004·Blood·Guido FinazziUNKNOWN ECLAP Investigators
Feb 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roberto MarchioliTiziano Barbui
Jul 28, 2005·Cancer·Francesco PassamontiMario Lazzarino
Jul 1, 2006·Blood·Craig KovitzJorge Cortes
Mar 17, 2007·Blood·Alexandre TheocharidesRadek C Skoda
Jul 7, 2007·British Journal of Haematology·Naseema GangatAyalew Tefferi
Mar 21, 2008·Annals of Hematology·Birgitta SwolinJan Westin
Jun 21, 2008·Blood·Constantine S TamSrdan Verstovsek
Jul 16, 2010·Leukemia·F PassamontiM Cazzola
Feb 4, 2011·The New England Journal of Medicine·Ashot HarutyunyanRobert Kralovics
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Magnus BjörkholmOla Landgren
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph RölligGerhard Ehninger
Jan 17, 2012·Blood·Tiziano BarbuiAyalew Tefferi
Mar 16, 2013·Leukemia & Lymphoma·Matjaz SeverSrdan Verstovsek
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Jun 7, 2013·Leukemia·A TefferiT Barbui
Jul 3, 2013·Cytogenetic and Genome Research·A SimonsR J Hastings
Dec 25, 2013·Current Opinion in Hematology·Raajit Rampal, John Mascarenhas
Jan 31, 2014·Blood·Pontus LundbergRadek C Skoda
Jun 28, 2014·American Journal of Hematology·Glen J TitmarshLesley A Anderson
Jul 20, 2014·Blood·Ayalew TefferiAlessandro M Vannucchi
Sep 6, 2014·Best Practice & Research. Clinical Haematology·Magnus BjörkholmÅsa Rangert Derolf
Jan 13, 2015·Leukemia Research·Chi Young OkSa A Wang
Jul 18, 2015·American Journal of Clinical Pathology·Magdalena Czader, Attilio Orazi
Sep 2, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brady L SteinRonald Hoffman
Nov 14, 2015·Blood Cancer Journal·S Cerquozzi, A Tefferi
Feb 18, 2016·Oncotarget·Rashmi Kanagal-ShamannaCarlos E Bueso-Ramos
Jul 14, 2016·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Władysław B GawełSławomira Kyrcz-Krzemień
Dec 20, 2016·American Journal of Hematology·Ayalew Tefferi, Tiziano Barbui
May 6, 2017·Haematologica·Guilin TangCarlos E Bueso-Ramos